Treasurer of the State of North Carolina’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
40,234
+855
+2% +$32K 0.01% 886
2025
Q4
$1.37M Sell
39,379
-2,878
-7% -$226K ﹤0.01% 916
2025
Q3
$3.51M Sell
42,257
-1,643
-4% -$119K 0.01% 741
2025
Q2
$3.22M Buy
+43,900
New +$3.18M 0.01% 781

Other funds holding CORT

Treasurer of the State of North Carolina's CORT Position: Q1 2026 in Review

Treasurer of the State of North Carolina increased its Corcept Therapeutics (CORT) stake by 2.2% in Q1 2026, buying an estimated $32K and bringing the position to 40,234 shares worth $1.62M. The position accounts for 0.01% of the portfolio, ranked #886.

Treasurer of the State of North Carolina first reported a position in CORT in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.51M in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Treasurer of the State of North Carolina held 40,234 shares of Corcept Therapeutics worth $1.62M as of Q1 2026.
  • Treasurer of the State of North Carolina bought 855 Corcept Therapeutics shares in Q1 2026, an estimated $32K.
  • Corcept Therapeutics made up 0.01% of Treasurer of the State of North Carolina's portfolio in Q1 2026, its #886 holding.
  • Treasurer of the State of North Carolina first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Treasurer of the State of North Carolina's Corcept Therapeutics position peaked at $3.51M in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Treasurer of the State of North Carolina's 13F filing for Q1 2026, filed 14 May 2026.